 Granville Lloyd
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Hyperplasia | 10 | 2024 | 40 | 4.140 |
Why?
| | Lower Urinary Tract Symptoms | 8 | 2024 | 62 | 3.960 |
Why?
| | Erectile Dysfunction | 3 | 2022 | 38 | 1.740 |
Why?
| | Prostatic Neoplasms | 4 | 2024 | 981 | 1.390 |
Why?
| | Global Burden of Disease | 2 | 2021 | 24 | 1.320 |
Why?
| | Urologists | 2 | 2019 | 17 | 1.190 |
Why?
| | Prostatitis | 2 | 2019 | 17 | 1.180 |
Why?
| | Prostate | 3 | 2024 | 159 | 0.960 |
Why?
| | Nephrectomy | 4 | 2022 | 163 | 0.760 |
Why?
| | Urinary Diversion | 1 | 2022 | 13 | 0.750 |
Why?
| | Hypogonadism | 2 | 2022 | 93 | 0.740 |
Why?
| | Urinary Retention | 2 | 2019 | 24 | 0.730 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 68 | 0.720 |
Why?
| | Buschke-Lowenstein Tumor | 1 | 2021 | 1 | 0.700 |
Why?
| | Kidney Neoplasms | 3 | 2022 | 414 | 0.650 |
Why?
| | Soft Tissue Neoplasms | 1 | 2021 | 131 | 0.620 |
Why?
| | Robotic Surgical Procedures | 1 | 2022 | 185 | 0.610 |
Why?
| | Carcinoma, Renal Cell | 1 | 2022 | 230 | 0.600 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 258 | 0.600 |
Why?
| | Low Back Pain | 1 | 2019 | 108 | 0.530 |
Why?
| | Occupational Diseases | 1 | 2019 | 165 | 0.520 |
Why?
| | Marijuana Smoking | 1 | 2021 | 249 | 0.520 |
Why?
| | Social Determinants of Health | 1 | 2021 | 309 | 0.500 |
Why?
| | Genital Neoplasms, Male | 1 | 2016 | 4 | 0.490 |
Why?
| | Liposarcoma | 1 | 2016 | 31 | 0.480 |
Why?
| | Urological Agents | 1 | 2016 | 3 | 0.470 |
Why?
| | Hernia, Inguinal | 1 | 2016 | 43 | 0.470 |
Why?
| | Ureteral Calculi | 1 | 2016 | 15 | 0.470 |
Why?
| | Urinary Bladder | 2 | 2022 | 196 | 0.450 |
Why?
| | Cannabis | 1 | 2022 | 510 | 0.440 |
Why?
| | Surgeons | 1 | 2019 | 340 | 0.430 |
Why?
| | Depression | 2 | 2022 | 1557 | 0.420 |
Why?
| | Male | 25 | 2026 | 73003 | 0.420 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1150 | 0.410 |
Why?
| | Adenocarcinoma | 1 | 2021 | 926 | 0.390 |
Why?
| | Hypertension | 1 | 2022 | 1276 | 0.390 |
Why?
| | Penile Prosthesis | 1 | 2012 | 3 | 0.380 |
Why?
| | Urinary Reservoirs, Continent | 1 | 2012 | 5 | 0.370 |
Why?
| | Replantation | 1 | 2012 | 32 | 0.370 |
Why?
| | Recreation | 1 | 2012 | 29 | 0.360 |
Why?
| | Lubricants | 1 | 2011 | 3 | 0.350 |
Why?
| | Menstrual Hygiene Products | 1 | 2011 | 6 | 0.350 |
Why?
| | Biopsy | 4 | 2024 | 1082 | 0.350 |
Why?
| | Sulfonamides | 1 | 2016 | 583 | 0.350 |
Why?
| | Retroperitoneal Space | 1 | 2011 | 18 | 0.350 |
Why?
| | Humans | 30 | 2026 | 145763 | 0.340 |
Why?
| | Salvage Therapy | 1 | 2012 | 165 | 0.340 |
Why?
| | Pelvis | 1 | 2012 | 125 | 0.340 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1331 | 0.340 |
Why?
| | Abdominal Injuries | 1 | 2012 | 130 | 0.330 |
Why?
| | Vena Cava Filters | 1 | 2011 | 64 | 0.320 |
Why?
| | Foreign Bodies | 1 | 2011 | 110 | 0.310 |
Why?
| | Pregnancy Complications | 1 | 2016 | 603 | 0.310 |
Why?
| | Veterans | 1 | 2022 | 1642 | 0.300 |
Why?
| | Ergonomics | 2 | 2019 | 29 | 0.300 |
Why?
| | Aged | 10 | 2026 | 26215 | 0.300 |
Why?
| | Urban Population | 1 | 2012 | 494 | 0.290 |
Why?
| | Endoscopy | 1 | 2011 | 317 | 0.280 |
Why?
| | Wounds, Nonpenetrating | 1 | 2012 | 321 | 0.280 |
Why?
| | Inflammation | 1 | 2019 | 2883 | 0.270 |
Why?
| | Image-Guided Biopsy | 2 | 2024 | 41 | 0.250 |
Why?
| | Penile Neoplasms | 1 | 2026 | 7 | 0.240 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1372 | 0.240 |
Why?
| | Neoplasms, Second Primary | 1 | 2026 | 102 | 0.220 |
Why?
| | Steam | 1 | 2024 | 14 | 0.210 |
Why?
| | Kidney | 1 | 2012 | 1496 | 0.210 |
Why?
| | Wounds and Injuries | 1 | 2012 | 962 | 0.200 |
Why?
| | Orchitis | 1 | 2003 | 5 | 0.200 |
Why?
| | Oligospermia | 1 | 2003 | 13 | 0.200 |
Why?
| | Trichomonas Infections | 1 | 2003 | 11 | 0.200 |
Why?
| | Trichomonas vaginalis | 1 | 2003 | 11 | 0.200 |
Why?
| | Prostatectomy | 1 | 2024 | 94 | 0.200 |
Why?
| | Cystectomy | 1 | 2022 | 42 | 0.180 |
Why?
| | Rectum | 1 | 2024 | 182 | 0.180 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5428 | 0.180 |
Why?
| | Physical Conditioning, Animal | 1 | 2024 | 242 | 0.180 |
Why?
| | Endocannabinoids | 1 | 2022 | 56 | 0.170 |
Why?
| | Groin | 1 | 2021 | 13 | 0.170 |
Why?
| | Disease Progression | 2 | 2019 | 2865 | 0.170 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2026 | 641 | 0.170 |
Why?
| | Quality-Adjusted Life Years | 1 | 2021 | 125 | 0.170 |
Why?
| | Tomography, X-Ray Computed | 5 | 2016 | 2770 | 0.160 |
Why?
| | Clinical Clerkship | 1 | 2021 | 109 | 0.150 |
Why?
| | Urinary Tract Physiological Phenomena | 1 | 2019 | 1 | 0.150 |
Why?
| | Insurance Coverage | 1 | 2021 | 244 | 0.150 |
Why?
| | Urinary Tract | 1 | 2019 | 47 | 0.150 |
Why?
| | Retrospective Studies | 5 | 2026 | 17325 | 0.140 |
Why?
| | Time Factors | 2 | 2021 | 7133 | 0.140 |
Why?
| | Risk Assessment | 3 | 2019 | 3752 | 0.140 |
Why?
| | Education, Medical, Undergraduate | 1 | 2021 | 208 | 0.140 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8346 | 0.140 |
Why?
| | Education, Medical | 1 | 2021 | 276 | 0.140 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 528 | 0.140 |
Why?
| | Adult | 8 | 2026 | 40872 | 0.130 |
Why?
| | Students, Medical | 1 | 2021 | 378 | 0.120 |
Why?
| | Acute Disease | 1 | 2019 | 1036 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2019 | 507 | 0.120 |
Why?
| | Global Health | 1 | 2019 | 403 | 0.120 |
Why?
| | Liability, Legal | 1 | 2016 | 42 | 0.110 |
Why?
| | Malpractice | 1 | 2016 | 44 | 0.110 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5992 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 583 | 0.110 |
Why?
| | Medicare | 1 | 2021 | 904 | 0.110 |
Why?
| | Ultrasonography | 1 | 2019 | 788 | 0.110 |
Why?
| | Middle Aged | 9 | 2026 | 36302 | 0.110 |
Why?
| | Flank Pain | 2 | 2011 | 9 | 0.110 |
Why?
| | Specialization | 1 | 2016 | 137 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 6085 | 0.110 |
Why?
| | Female | 8 | 2022 | 79035 | 0.100 |
Why?
| | Safety | 1 | 2016 | 358 | 0.100 |
Why?
| | Alcohol Drinking | 1 | 2021 | 843 | 0.100 |
Why?
| | Aging | 1 | 2024 | 1973 | 0.100 |
Why?
| | Kidney Pelvis | 1 | 2012 | 22 | 0.090 |
Why?
| | Incidence | 2 | 2026 | 2933 | 0.090 |
Why?
| | Registries | 1 | 2021 | 2410 | 0.090 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2012 | 7 | 0.090 |
Why?
| | Prevalence | 1 | 2019 | 2874 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1512 | 0.090 |
Why?
| | Urban Health | 1 | 2012 | 96 | 0.090 |
Why?
| | Venae Cavae | 1 | 2011 | 7 | 0.090 |
Why?
| | Trauma Severity Indices | 1 | 2012 | 115 | 0.090 |
Why?
| | Urination | 2 | 2024 | 47 | 0.090 |
Why?
| | Renal Veins | 1 | 2011 | 18 | 0.090 |
Why?
| | Ureteral Obstruction | 1 | 2012 | 63 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3915 | 0.090 |
Why?
| | Pelvic Neoplasms | 1 | 2011 | 24 | 0.090 |
Why?
| | Angiomyolipoma | 1 | 2011 | 21 | 0.090 |
Why?
| | Stromal Cells | 1 | 2012 | 121 | 0.080 |
Why?
| | Radiographic Image Enhancement | 1 | 2011 | 57 | 0.080 |
Why?
| | Robotics | 1 | 2012 | 90 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2933 | 0.080 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 58 | 0.080 |
Why?
| | Laparoscopy | 2 | 2012 | 481 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2022 | 11793 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2022 | 2977 | 0.080 |
Why?
| | Accidental Falls | 1 | 2012 | 230 | 0.070 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 228 | 0.070 |
Why?
| | Obesity | 1 | 2022 | 3118 | 0.070 |
Why?
| | United States | 2 | 2022 | 16123 | 0.060 |
Why?
| | Urination Disorders | 1 | 2005 | 15 | 0.060 |
Why?
| | SEER Program | 1 | 2026 | 230 | 0.060 |
Why?
| | Epithelial Cells | 1 | 2012 | 1134 | 0.060 |
Why?
| | Autonomic Nervous System | 1 | 2005 | 83 | 0.050 |
Why?
| | Risk Factors | 2 | 2026 | 10917 | 0.050 |
Why?
| | Age Factors | 2 | 2024 | 3346 | 0.050 |
Why?
| | Antitrichomonal Agents | 1 | 2003 | 1 | 0.050 |
Why?
| | Metronidazole | 1 | 2003 | 20 | 0.050 |
Why?
| | Sperm Motility | 1 | 2003 | 37 | 0.050 |
Why?
| | Pregnancy | 1 | 2016 | 7215 | 0.050 |
Why?
| | Colorado | 1 | 2012 | 4556 | 0.040 |
Why?
| | Frailty | 1 | 2024 | 205 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2024 | 520 | 0.040 |
Why?
| | Insurance, Health | 1 | 2022 | 311 | 0.040 |
Why?
| | Urinary Bladder Neck Obstruction | 1 | 2019 | 19 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 14251 | 0.030 |
Why?
| | Adolescent | 3 | 2012 | 22573 | 0.030 |
Why?
| | Cohort Studies | 2 | 2022 | 6032 | 0.030 |
Why?
| | Parietal Bone | 1 | 1995 | 9 | 0.030 |
Why?
| | Animals | 3 | 2024 | 38097 | 0.030 |
Why?
| | Bone Cysts | 1 | 1995 | 12 | 0.030 |
Why?
| | Epidermal Cyst | 1 | 1995 | 13 | 0.030 |
Why?
| | Head Injuries, Closed | 1 | 1995 | 49 | 0.030 |
Why?
| | Mice | 2 | 2024 | 18355 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 1074 | 0.030 |
Why?
| | Brain Diseases | 1 | 1995 | 155 | 0.030 |
Why?
| | Clinical Competence | 1 | 2021 | 1247 | 0.020 |
Why?
| | Operative Time | 1 | 2012 | 181 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2012 | 113 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2012 | 249 | 0.020 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2012 | 189 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2012 | 85 | 0.020 |
Why?
| | Embolization, Therapeutic | 1 | 2011 | 243 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1723 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 1350 | 0.010 |
Why?
| | Tilt-Table Test | 1 | 2005 | 8 | 0.010 |
Why?
| | Hemorrhage | 1 | 2011 | 822 | 0.010 |
Why?
| | Catecholamines | 1 | 2005 | 88 | 0.010 |
Why?
| | Urodynamics | 1 | 2005 | 44 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1329 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 181 | 0.010 |
Why?
| | Multicenter Studies as Topic | 1 | 2005 | 413 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1547 | 0.010 |
Why?
| | Brain Edema | 1 | 1995 | 62 | 0.010 |
Why?
| | Craniotomy | 1 | 1995 | 84 | 0.010 |
Why?
| | Quality of Life | 1 | 2005 | 3210 | 0.010 |
Why?
|
|
Lloyd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|